Management Team:

Joel Z. Melnick, MD Vice President, Clinical Research and Development

Dr. Melnick joined Cytochroma in August 2007 initially as Vice President, Clinical and Regulatory Affairs, and has held the role of Vice President, Clinical Research and Development since September 2008. Prior to joining Cytochroma, he was Senior Medical Director in the Global Pharmaceutical Research and Development Group at Abbott Laboratories (North Chicago, IL). While at Abbott, Dr. Melnick managed clinical trials, regulatory submissions, marketing approvals and post-launch support for Zemplar® (paricalcitol) Capsules and Injection, currently one of the world’s leading vitamin D hormone therapies for SHPT in CKD. Prior to Abbott, Dr. Melnick served as Assistant Professor of Pediatrics at Northwestern University, where he conducted research in metabolism and cardio-renal disease. Dr. Melnick completed his medical degree, internship, and residency in internal medicine and pediatrics at the Creighton University Medical Center, and completed a post-doctoral fellowship in pediatric and adult nephrology at the University of Texas Southwestern Medical Center.